Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-01

Clinical Trial Update: A Novel Oral Synbiotic Formula in Reducing Advanced Adenoma Recurrence and Colorectal Neoplasia-related Bacterial Gene Markers [NA]

View source ↗

Summary

A novel oral synbiotic formula is being studied in a recruiting clinical trial to reduce recurrence of advanced colorectal adenomas and to modulate bacterial ge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Novel oral synbiotic formula

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Colorectal Neoplasms, Colorectal Adenoma | NA | Status: RECRUITING